The updated original online version for this chapter can be found at 10.1007/978-3-319-43099-7_34
You have full access to this open access chapter, Download chapter PDF
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Erratum to: “European Medicines Agency (EMA): Regulatory Perspectives on Geriatric Medicines” in: S. Stegemann (ed.), Developing Drug Products in an Aging Society, 10.1007/978-3-319-43099-7_34
The name of the co-author, David Bowen, was missed in the chapter titled, European Medicines Agency (EMA): Regulatory Perspectives on Geriatric Medicines, and also in the Table of Contents and List of Contributors. The original chapter and the erratum book has been updated with the correction.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Cerreta, F., Bowen, D. (2016). Erratum to: European Medicines Agency (EMA): Regulatory Perspectives on Geriatric Medicines. In: Stegemann, S. (eds) Developing Drug Products in an Aging Society. AAPS Advances in the Pharmaceutical Sciences Series, vol 26. Springer, Cham. https://doi.org/10.1007/978-3-319-43099-7_38
Download citation
DOI: https://doi.org/10.1007/978-3-319-43099-7_38
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43097-3
Online ISBN: 978-3-319-43099-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)